ARCA biopharma logo
ARCA biopharma ABIO

Quartalsbericht 2025-Q3
hinzugefügt 12.11.2025

report update icon

ARCA biopharma Langfristiger Schuldenstrom 2011-2026 | ABIO

Langfristiger Schuldenstrom Jährlich ARCA biopharma

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
213 K 76 K 103 K - - 25 K - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
213 K 25 K 104 K

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
Assembly Biosciences Assembly Biosciences
ASMB
569 K $ 28.46 3.45 % $ 319 M usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
14.2 M $ 221.88 -0.87 % $ 5 B danmarkDanmark
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Axsome Therapeutics Axsome Therapeutics
AXSM
434 K $ 156.92 -1.23 % $ 7.81 B usaUSA
Galera Therapeutics Galera Therapeutics
GRTX
133 K - -32.59 % $ 7.61 M usaUSA
Pharming Group N.V. Pharming Group N.V.
PHAR
1.6 M $ 15.36 -0.71 % $ 7.59 B niderlandNiderland
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
5.05 M $ 1.37 -4.2 % $ 350 M britainBritain
Kamada Ltd. Kamada Ltd.
KMDA
2.12 M $ 8.5 -1.39 % $ 260 M israelIsrael
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Benitec Biopharma Benitec Biopharma
BNTC
354 K $ 10.98 -4.52 % $ 452 M usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
768 K $ 2.09 -0.95 % $ 195 M israelIsrael
Tiziana Life Sciences PLC Tiziana Life Sciences PLC
TLSA
106 K $ 1.21 -3.97 % $ 71.5 M britainBritain
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
Foghorn Therapeutics Foghorn Therapeutics
FHTX
923 K $ 5.0 2.25 % $ 315 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
5.82 M $ 3.4 -3.68 % $ 1.02 B canadaCanada
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
8.57 M $ 54.13 -1.64 % $ 10.4 B usaUSA
Curis Curis
CRIS
1.34 M $ 0.77 1.89 % $ 4.86 M usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
203 K - -74.18 % $ 955 K usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
428 K - -10.17 % $ 12.2 K usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
1.83 M $ 1.52 -5.59 % $ 178 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Cellectis S.A. Cellectis S.A.
CLLS
7.7 M $ 3.34 -4.02 % $ 116 M franceFrance
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
425 K $ 4.24 -2.97 % $ 704 M canadaCanada
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
410 K - 1.93 % $ 17.4 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
730 K $ 1.8 -1.1 % $ 120 M usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
3.56 M $ 2.94 -3.29 % $ 3.43 M usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
67 K $ 0.16 -5.45 % $ 3.15 M irlandaIrlanda
Brickell Biotech Brickell Biotech
BBI
49 K - -5.38 % $ 6.06 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA